Rare diseases
Investigational molecules
Locations
Back to Germany433 clinical trials in Kiel, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
GermanyTesting SAR442970 compared to placebo in adults with moderate to severe Crohn's disease
GermanyStudy on the Effectiveness of EscharEx and Amnion/Chorion Membrane Allograft for Patients with Venous Leg Ulcers
GermanyStudy on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis
GermanyStudy on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen
GermanyStudy comparing rilvegostomig plus chemotherapy versus pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression
GermanyStudy on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
GermanyStudy on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease
GermanyStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
GermanyPhase 3 Study of Subcutaneous vs Intravenous Tarlatamab with Siltuximab in Relapsed Extensive-Stage Small Cell Lung Cancer after Platinum Chemotherapy
GermanyEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
GermanyEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on breast cancer treatments, including studies of ribociclib with endocrine therapy for HR-positive, HER2-negative cases. Additional research encompasses various blood cancers, including lymphomas and leukemia.
Cutting-edge research evaluating novel therapeutic combinations and treatment approaches for better patient outcomes.
Comprehensive research into chronic skin conditions, including trials for plaque psoriasis and atopic dermatitis. Studies evaluate new therapeutic agents for moderate to severe cases.
Focus on developing effective treatments for persistent skin conditions that significantly impact quality of life.
Advanced studies in inflammatory bowel diseases, particularly Crohn's disease and ulcerative colitis. Trials investigate innovative therapies for moderate to severe cases.
Investigation of new therapeutic options for patients with inadequate response to conventional treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
